Melanoma Journal Articles for May 2019
JAMA Dermatology
Original Investigation
May 1, 2019
Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor
Lena A. von Schuckmann, MBBS, MPH1,2; Maria Celia B. Hughes, MMedSci1; Reza Ghiasvand, PhD3; et alMaryrose Malt, BBus1; Jolieke C. van der Pols, PhD4; Vanessa L. Beesley, PhD1; Kiarash Khosrotehrani, MD, PhD5,6; B. Mark Smithers, MBBS7; Adele C. Green, MBBS, PhD1,8
Author Affiliations Article Information
JAMA Dermatol. Published online May 1, 2019. doi:10.1001/jamadermatol.2019.0440
JAMA Dermatology
Original Investigation
May 1, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival
Anaïs Vallet, MD1; Bastien Oriano, MS2; Laurent Mortier, MD, PhD3; et alStéphane Dalle, MD, PhD4; Caroline Dutriaux, MD5; Bernard Guillot, MD, PhD6; Marie-Thérèse Leccia, MD, PhD7; Sophie Dalac, MD8; Philippe Saiag, MD, PhD9; Jean-Philippe Lacour, MD, PhD10; Delphine Legoupil, MD11; Julie De Quatrebarbes, MD12; Florence Brunet-Possenti, MD13; Thierry Lesimple, MD, PhD14; Jean-Philippe Arnault, MD15; François Aubin, MD, PhD16; Florence Granel-Brocard, MD17; Pierre-Emmanuel Stoebner, MD, PhD18; Eve Maubec, MD, PhD19; Brigitte Dreno, MD, PhD20; Clara Allayous, PhD1; Raphaël Porcher, PhD2; Céleste Lebbé, MD, PhD1; for MelBase
Author Affiliations Article Information
JAMA Dermatol. Published online May 1, 2019. doi:10.1001/jamadermatol.2019.0425
JAMA Dermatology
Original Investigation
May 1, 2019
Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma
Laura Calomarde-Rees, MD1; Rosario García-Calatayud, MD2; Celia Requena Caballero, MD, PhD1; et alEsperanza Manrique-Silva, MD1; Víctor Traves, MD3; Zaida García-Casado, PhD4; Virtudes Soriano, MD5; Rajiv Kumar, PhD6; Eduardo Nagore, MD, PhD1,2
Author Affiliations Article Information
JAMA Dermatol. Published online May 1, 2019. doi:10.1001/jamadermatol.2019.0069
JAMA Dermatology
Editorial
May 1, 2019
The Changing Kinetics of Advanced Melanoma
Author Affiliations Article Information
JAMA Dermatol. Published online May 1, 2019. doi:10.1001/jamadermatol.2019.0200
American Chemical Society – Chemical Biology
JNK2 is required for tumorigenic properties of melanoma cells
Lili Du, Anna Anderson, Kimberly Nguyen, Sandra S. Ojeda, Ivannie Ortiz-Rivera, Tran Ngoc Nguyen, Tinghu Zhang, Tamer S Kaoud, Nathanael S Gray, Kevin N. Dalby, and Kenneth Y. Tsai
ACS Chem. Biol., Just Accepted Manuscript
DOI: 10.1021/acschembio.9b00083
Publication Date (Web): May 7, 2019
Copyright © 2019 American Chemical Society
Dove Press
miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGF?R1, GNAQ, WASL, and RAC1
Authors Peng D, Dong J, Zhao Y, Peng X, Tang J, Chen X, Wang L, Hu DN, Reinach PS, Qu J, Yan D
Received 22 February 2019
Accepted for publication 18 April 2019
Published 24 May 2019 Volume 2019:11 Pages 4729—4742
DOI https://doi.org/10.2147/CMAR.S206461
Molecular Cancer Research
NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties
Ying Wang, M. Kathryn Leonard, Devin E. Snyder, Matthew L. Fisher, Richard L. Eckert and David M Kaetzel
DOI: 10.1158/1541-7786.MCR-18-0019
Journal of Experimental & Clinical Cancer Research
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy
Huan Tang, Meng Ma, Jie Dai, Chuanliang Cui, Lu Si, Xinan Sheng, Zhihong Chi, Longwen Xu, Sifan Yu, Tianxiao Xu, Junya Yan, Huan Yu, Lu Yang, Yan Kong and Jun Guo
Journal of Experimental & Clinical Cancer Research201938:212
https://doi.org/10.1186/s13046-019-1190-3
- Received: 10 November 2018
- Accepted: 23 April 2019
- Published: 22 May 2019
Dove Press
Antitumor effects of conditioned media of human fetal dermal mesenchymal stem cells on melanoma cells
Authors Sun B, Wang X, Pan Y, Jiao Y, Qi Y, Gong H, Jiang D
Received 2 February 2019
Accepted for publication 12 April 2019
Published 28 May 2019 Volume 2019:12 Pages 4033—4046
DOI https://doi.org/10.2147/OTT.S203910
Dove Press
SKP2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27
Authors Zhao H, Pan H, Wang H, Chai P, Ge S, Jia R, Fan X
Received 1 February 2019
Accepted for publication 27 April 2019
Published 30 May 2019 Volume 2019:12 Pages 4297—4308
DOI https://doi.org/10.2147/OTT.S203888
BMC
Characteristics of Brazilian melanomas: real-world results before and after the introduction of new therapies
Letícia Maria Modes da Costa, Camila de Souza Crovador, Carlos Eduardo Barbosa de Carvalho and Vinicius de Lima Vazquez
BMC Research Notes 201912:296
https://doi.org/10.1186/s13104-019-4336-7
- Received: 28 March 2019
- Accepted: 22 May 2019
- Published: 28 May 2019
Molecular Cancer Research
AKT1E17K activates focal adhesion kinase and promotes melanoma brain metastasis
David A Kircher, Kirby A Trombetti, Mark R Silvis, Gennie L Parkman, Grant M. Fischer, Stephanie N Angel, Christopher M Stehn, Sean C Strain, Allie H. Grossmann, Keith L Duffy, Kenneth M Boucher, Martin McMahon, Michael A. Davies, Michelle C Mendoza, Matthew W. VanBrocklin and Sheri L Holmen
DOI: 10.1158/1541-7786.MCR-18-1372
Carcinogenesis
Reply to Flugge: The anti-metastatic potential of methionine restriction in melanoma
Isabelle R Miousse Julia Tobacyk Charles M Quick Azemat Jamshidi-ParsianCharles M Skinner Rajshekhar Kore Stepan B Melnyk Kristy R Kutanzi Fen XiaRobert J Griffin
Igor Koturbash
Carcinogenesis, bgz099, https://doi.org/10.1093/carcin/bgz099
Published: 29 May 2019
International Journal of Cancer
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target
Elias Orouji1,2,5, Aniello Federico1,2,5, Lionel Larribère1,2, Daniel Novak1,2, Daniel B. Lipka3 , Yassen Assenov3 , Sachindra1,2, Laura Hüser1,2, Karol Granados1,2, Christoffer Gebhardt1,2,4, Christoph Plass3 , Viktor Umansky1,2, and Jochen Utikal1,2 *
First published: 27 May 2019
https://doi.org/10.1002/ijc.32432